eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Comorbidity | C0011847|diabetes |
| Sentences | 158 |
| PubMedID- 20587704 | The study involved a group of 242 metabolic syndrome patients with or without pre-diabetes and randomized to atorvastatin, fenofibrate, or placebo. |
| PubMedID- 24843614 | Furthermore, some studies showed that fish intake reduced the rates of incidence for diabetes in patients with metabolic syndrome, and reduced the rates of death in patients with type 2 diabetes13,14. |
| PubMedID- 20376319 | Thirty-five patients undergoing bariatric surgery were classified as mho (n = 15) or metabolically unhealthy obese (muo, n = 20) according to cut-off points adapted from the international diabetes federation definition of the metabolic syndrome. |
| PubMedID- 23949560 | The insulin resistance milieu of type 2 diabetes is closely associated with metabolic syndrome—a clustering of risk factors that includes hypertension, abdominal adiposity, dyslipidemia, and inflammation. |
| PubMedID- 25995613 | The 2006 international diabetes federation (idf) definition of metabolic syndrome was used for this study.12 this definition requires central obesity to be present, which is defined as a waist circumference >94 cm for males and >80 cm for females. |
| PubMedID- 22113483 | Sensitivity analyses were undertaken using the revised ncep atp iii definition (glucose cut point >5.6mmol/l) and the international diabetes federation (idf) definitions of metabolic syndrome (zimmet et al., 2005). |
| PubMedID- 24744548 | [27] on the other hand, the drugs used to manage schizophrenics, though beneficial, have been reported to produce certain side effects such as considerable weight gain, diabetes, and risk of metabolic syndrome. |
| PubMedID- 24843651 | In patients with type 2 diabetes, the prevalence of metabolic syndrome‐oriented type 2 diabetes, which is characterized by insulin resistance16, increases as much as 45.9% in males and 28.0% in females17. |
| PubMedID- 23127161 | Lower adiponectin levels were observed in participants with the following characteristics: male, former smoking, hypertension, diabetes, homeostasis model assessment of insulin resistance (homa-ir), metabolic syndrome, moderate alcohol use, elevated waist circumference, bmi, estimated glomerular filtration rate (egfr), triglycerides, low-density lipoprotein cholesterol (ldl-c), lower high-density lipoprotein cholesterol (hdl-c), and younger age. |
| PubMedID- 26558285 | These findings suggest that enhanced glycolysis and the tca cycle might contribute to the development of diabetes associated with metabolic syndrome. |
| PubMedID- 21472664 | Colestimide appeared to be useful in the management of japanese patients with diabetes mellitus complicated by metabolic syndrome, since it alleviates obesity and insulin resistance in addition to exhibiting lipid profile-improving effects, and can thus improve markers of atherosclerosis. |
| PubMedID- 21055836 | Methods: 150 men were recruited from a genetic screening programme for hereditary hemocromatosis (hh) and were tested for type 2 diabetes, other components of the metabolic syndrome, beta cell function (bcf), insulin sensitivity, high-sensitivity c-reactive protein and iron overload. |
| PubMedID- 21749444 | Methods: cox models were developed to assess the risk of new-onset diabetes associated with the metabolic syndrome after adjusting for a priori confounders (age, sex, ethnicity and concomitant use of non-cardiovascular medications), its individual components and other determinants of new-onset diabetes. |
| PubMedID- 21423680 | To evaluate whether body fat distribution, birth weight, and family history for diabetes (fhd) were associated with metabolic syndrome (mets) in children and adolescents. |
| PubMedID- 21390196 | Fifty nine had isolated metabolic syndrome (group a) and 97 had metabolic syndrome with hypertension and/or diabetes (group b). |
| PubMedID- 22370155 | The influence on the prevalence of metabolic syndrome was greater with the international diabetes federation (idf) criteria (19.3-23.9% in men and 29.4-43.1% in women) than with the adult treatment panel iii (atp iii) criteria (26.1-28.6% in men and 37.3-44.1% in women). |
| PubMedID- 21994347 | This review focuses on their role in cardiovascular diseases with emphasis on their implication in the inflammatory processes that accompany heart failure, atherosclerosis, coronary artery disease, and finally obesity and diabetes as components of the ageing-associated metabolic syndrome. |
| PubMedID- 21315688 | Taken together, these results may provide evidence of the therapeutic potential of kr-66344, as a 11beta-hsd1 inhibitor, in obesity and type 2 diabetes patients with metabolic syndrome. |
| PubMedID- 25729439 | Furthermore, the cardia study showed a direct association between childbearing and incidence of metabolic syndrome among women with gestational diabetes mellitus but not among women without it [8]. |
| PubMedID- 20566663 | To conclude, we have found that patients fulfilling the international diabetes federation criteria of metabolic syndrome have increased brain ffa uptake when compared with healthy subjects. |
| PubMedID- 25663951 | Conclusions: cynical hostility may increase the risk for developing diabetes and worsening of the metabolic syndrome in postmenopausal women. |
| PubMedID- 23913501 | The prevalence of metabolic syndrome in persons with type 2 diabetes at the lagos university tteaching hospital, lagos, nigeria. |
| PubMedID- 20813084 | [overweight, obesity and metabolic syndrome in children with type 1 diabetes melllitus]. |
| PubMedID- 25761114 | Some studies indicated that hypertension and type 2 diabetes were associated with metabolic syndrome (mets) [12]. |
| PubMedID- 21140273 | Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy. |
| PubMedID- 21448316 | To identify risk factors associated with metabolic syndrome in patients with type 2 diabetes mellitus according to three diagnostic criteria: world health organization (who), third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults – adult treatment panel iii (ncep-atp iii), and international diabetes federation (idf). |
| PubMedID- 26457580 | Abbreviation: frs, framingham risk score; mets-idf, international diabetes foundation definition of metabolic syndrome; mets-ncep, national cholesterol education program-defined metabolic syndrome; vat: visceral adipose tissue. |
| PubMedID- 20653460 | In this paper the relationship between depression and the metabolic syndrome among patients with type 1 diabetes was evaluated. |
| PubMedID- 20153706 | Conclusions: the prevalence of metabolic syndrome in patients with type 2 diabetes in spain is high, even when the low consistency among who, ncep-atp iii and idf criteria is considered. |
| PubMedID- 25699225 | diabetes is a group of metabolic syndromes and falls into two groups. |
| PubMedID- 20178560 | Patients with chc may develop hepatic steatosis as a consequence of concomitant metabolic syndrome, possibly associated with type 2 diabetes, obesity or increased body mass index (bmi). |
| PubMedID- 20334808 | Conclusions: metabolic syndrome was common in patients with type-1 diabetes and was associated with microvascular complications. |
| PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
| PubMedID- 22311446 | metabolic syndrome was defined with the international diabetes federation (idf) criteria. |
| PubMedID- 24411997 | However, few studies are available on the impact of sleep duration on metabolic syndrome in patients with diabetes, who were at high risk for cardiovascular diseases (cvd). |
| PubMedID- 22322078 | Pre-diabetes commonly associates with the metabolic syndrome. |
| PubMedID- 21892559 | Nonalcoholic fatty liver disease (nafld) is the most important cause of chronic liver disease and is considered the hepatic manifestation of the metabolic syndrome associated with diabetes mellitus type 2. |
| PubMedID- 22328881 | The studies incorporated in the present analysis are:assessing the treatment effect in metabolic syndrome without perceptible diabetes (attempt) study, which included patients with mets but no dm or cvd [17];implementation of strategy for the management of overt dyslipidemia (improve-dyslipidemia) study, which included patients with dyslipidaemia with or without dm, with or without cvd [20];standardized arrangement for a guideline-driven treatment of the metabolic syndrome (sage-mets) study, which included patients with mets but no cvd [21];implementation of guidelines for the management of arterial hypertension (impulsion) study, which included patients with hypertension with or without dm but no cvd [22];initiative for a new diabetes therapeutic approach in a mediterranean country (indeed) study, which included patients with diabetes but no cvd [23]. |
| PubMedID- 25258634 | Background: diabetes mellitus, one of the leading metabolic syndromes, accounts for highest morbidity and mortality worldwide. |
| PubMedID- 21688564 | Nafld as the hepatic manifestation of the metabolic syndrome (ms) is associated with obesity, diabetes mellitus and dislipidemia. |
| PubMedID- 22762010 | Serum levels of c-peptide are associated with the metabolic syndrome in patients with type 2 diabetes and in diabetic patients with nephropathy and vascular disease [37]. |
| PubMedID- 23282254 | diabetes affects approximately 4% of world's population and metabolic syndrome has been directly related to obesity. |
| PubMedID- 20529259 | The international diabetes federation (idf) definition of the metabolic syndrome is [15]: central obesity (waist circumference ≥ 94 cm in men, ≥ 80 cm in women) and at least two of the following factors: (1) triglycerides ≥ 1.70 mmol/l or specific treatment for this lipid abnormality; (2) hdl-cholesterol < 1.03 mmol/l in men and < 1.29 mmol/l in women or specific treatment for this lipid abnormality; (3) systolic blood pressure ≥ 130 mm hg or diastolic blood pressure ≥ 85 mm hg or treatment for previously diagnosed hypertension; (4) fasting plasma glucose ≥ 5.6 mmol/l or previously diagnosed type 2 diabetes. |
| PubMedID- 22695027 | In general, patients with type 2 diabetes commonly have components of metabolic syndrome (e.g. |
| PubMedID- 22622313 | [prevalence of metabolic syndrome (ms) in patients with type 1 diabetes (dm1)]. |
| PubMedID- 25550516 | These findings are important to consider in designing drugs to target type 2 diabetes and other features of the "metabolic syndrome." medical school, boston, ma 02115; school, boston, ma 02215; and. |
| PubMedID- 24285222 | metabolic syndrome was vigorously associated with diabetes mellitus and newly diagnosed diabetes mellitus (12.4% vs. |
| PubMedID- 24634611 | An increase in steady-state level of reactive carbonyls is the key cause of the phenomenon called carbonyl stress, a contributing factor to aging, pathogenesis of metabolic syndrome, chronic complications associated with diabetes and renal failure, neurodegenerative, and other disorders [1–9]. |
| PubMedID- 21061066 | The international diabetes federation (idf) definition of the metabolic syndrome of those from south and south-east asian are; central obesity (defined as waist circumference) ≥80 cm, plus any two of the following four factors: raised triglycerides; ≥1.7 mmol/l, reduced hdl-cholesterol <1.29 mmol/l in females, raised blood pressure; systolic bp ≥130 or diastolic bp ≥85 mmhg, or impaired fasting glycaemia (ifg); fasting plasma glucose ≥5.6 mmol/l [3–5]. |
| PubMedID- 21525475 | In a subanalysis of allhat, chlorthalidone was superior to the other agents in preventing hf in participants with the metabolic syndrome and in patients with diabetes (18). |